Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.
about
Matrix metalloproteinases in stem cell regulation and cancerAPRIL is overexpressed in cancer: link with tumor progressionHigh-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignanciesDiffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathologyT-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.SRC induces podoplanin expression to promote cell migrationOncogenic activation of NF-kappaB.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment.Vitamin D3 receptor is highly expressed in Hodgkin's lymphomamCOPA: analysis of heterogeneous features in cancer expression data.NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomasRecent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.New roles for old modifications: emerging roles of N-terminal post-translational modifications in development and disease.Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.Hodgkin lymphoma.Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation.Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma.Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacityAberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.TET1 is a tumor suppressor of hematopoietic malignancySeveral immune escape patterns in non-Hodgkin's lymphomas.NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.SRC points the way to biomarkers and chemotherapeutic targets.miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse modelAberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.RECQ helicases are deregulated in hematological malignancies in association with a prognostic valueA roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma.New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.Thermoresponsive Collagen/Cell Penetrating Hybrid Peptide as Nanocarrier in Targeting-Free Cell Selection and Uptake.Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
P2860
Q26825295-151EAA96-49D1-4ACF-80C6-65314DEEBF8AQ33418752-B3E5041E-8470-4040-9B4D-C5F37D15FEC2Q33566475-7F65FB5D-DD86-4F84-9EE7-0A33D280D37FQ33647319-E20144AE-5708-4811-B430-B9161E523FBBQ33707435-320CCAAF-A497-48DB-B9D6-BF2BFFE3BC23Q33744623-A07385A9-3E55-40AA-9847-1AB09E6F8026Q33849388-6D5062EC-A901-4721-AACC-D17C0DA5895AQ33889168-60880D8B-1AE7-4F60-B6A5-0384C17901E4Q34235750-5EE3AACD-28C8-46EC-9BC5-DD13242A5667Q34294390-2BAE6D9B-6B11-401E-9118-7643E7E4C36CQ34502379-451DE7E4-26AF-4B9C-A158-1F755C4DE5A4Q34509143-1EA6F07A-7ECC-45A6-B0E6-E5B5A0AE9CE8Q34557179-643675C5-C6E9-47CD-AC66-D5078F008854Q34621284-9AE7A296-CBE9-4ABD-8907-2AEBDEE803ECQ34627655-D2502822-A605-4D42-AB34-AE2158AF11EFQ34643277-6BD351BF-2463-410D-9BBA-AF3BE30554DEQ34650591-0F927417-2C2E-48E5-8879-1352E1AFC278Q34749867-E712766A-B3C8-4AFD-8FC6-1BB08E9F69BEQ34801504-97261649-F144-45E5-9DBB-495067D22EB9Q35018530-28FEE234-8008-4794-9B35-C2265EE14407Q35063947-9CEF7BC4-4870-44D2-B399-13D01E6A72B7Q35078505-D2EB7438-45FB-4548-8079-9C29DAF5CFE0Q35788374-CF686912-ABD8-4C08-AC30-8AA175FD8A1EQ35875897-8DE38A2C-7C68-4829-AE89-EADEF43CE77DQ35983746-8D7A2A13-6AEC-43BF-8DC5-0BF2B0060B1BQ36060357-A2CE1D8C-2341-4119-8B1B-858B33A1866AQ36267574-989D9199-2F33-46C2-B8BC-D447DCDD78ABQ36443406-1365A496-46AB-4343-B48F-AFFD4A19376BQ36471327-BC571D02-0428-42E5-BC96-443756E90C78Q36545556-9A2F7E51-0F24-43E3-A4A8-24F3486FAFB1Q36577713-406911BD-E5F7-497F-AC01-D77E90DE2665Q36694809-8462E310-6314-42A1-A475-0209B832E5B0Q36738950-DF67D69C-FEA8-4F09-BE25-49417007145EQ36780387-B60A3C67-39F7-4054-B961-25AA4EF8B594Q37269044-15FD1E4B-8FB6-44D5-AD80-CF58D27E4518Q37297662-89F22325-5026-451F-A3EF-86DC29E28004Q37392856-E9ECDA99-8EB7-42B9-8419-226AD7B5A7C5Q37525095-244C78B6-2EFE-4DAA-A7E2-7C63F6089DEBQ37593943-7283E111-6451-45DF-8722-E90FE8659E7AQ37618835-1FA03BA2-0BE4-47E5-BEF3-9B14DB15E95D
P2860
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Origin and pathogenesis of nod ...... obal gene expression analysis.
@en
Origin and pathogenesis of nod ...... obal gene expression analysis.
@nl
type
label
Origin and pathogenesis of nod ...... obal gene expression analysis.
@en
Origin and pathogenesis of nod ...... obal gene expression analysis.
@nl
prefLabel
Origin and pathogenesis of nod ...... obal gene expression analysis.
@en
Origin and pathogenesis of nod ...... obal gene expression analysis.
@nl
P2093
P2860
P50
P356
P1476
Origin and pathogenesis of nod ...... obal gene expression analysis.
@en
P2093
Andreas Bräuninger
Anja von Heydebreck
Carel J M van Noesel
Claudia Döring
Dirk Metzler
Enrico Tiacci
Ines Pfeil
Susan Eckerle
Verena Brune
Wolfram Klapper
P2860
P304
P356
10.1084/JEM.20080809
P407
P577
2008-09-15T00:00:00Z